Literature DB >> 17624201

Combination of acute stroke unit and short-term stroke ward with early supported discharge decreases mortality and complications after acute ischemic stroke.

Nijasri Charnnarong Suwanwela1, Nattapong Eusattasak, Kammant Phanthumchinda, Krisna Piravej, Chaichon Locharoenkul.   

Abstract

BACKGROUND: The stroke unit has been established as a standard care for stroke. However, it has not been widely established in developing countries due to the lack of understanding and limited resources.
OBJECTIVE: To compare the complications and mortality of stroke patients admitted in the stroke unit and short-term ward with those admitted in the general medical ward. MATERIAL AND
METHOD: The authors prospectively collected data of acute stroke patients who were admitted after the set up of the stroke unit and stroke short-term ward in 2003, and compared with the data of those who were admitted in a general medical ward in 2001. All acute stroke patients who presented within seven days of the onset were admitted and those who had final diagnosis of ischemic stroke or transient ischemic attack (TIA) were studied. Patients in the stroke unit were taken care of by a multidisciplinary team approach under clinical guidelines and a care map. The short-term ward is a part of the general medical ward and stroke patients were treated by a multidisciplinary team followed by homecare treatment. The endpoints were mortality rate, neurological and medical complications during admissions, and the mean length of stay.
RESULTS: Seven hundred and ninety-four patients were studied. Three hundred and eighty-seven patients were admitted in 2001 and 407 patients in 2003. Among patients presented 2003, three hundred and one cases were treated in the acute stroke unit whereas 106 were admitted in the short-term ward. There was no difference in stroke risk factors and stroke subtypes between the two groups, except for dyslipidemia and cigarette smoking, which were more prevalent in patients admitted in 2003. Patients in the stroke unit and the short-term ward had significantly less mortality than those in the general medical ward (8.9 and 2.1%). Overall complications in the stroke unit and the short-term ward were 16.8%, compared to 26% of those admitted into the general medical ward. Significantly less brain edema, hemorrhagic infarction, urinary tract infection, pneumonia, and pressure sore were also observed. The length of hospital stay of the patients admitted in 2001 and 2003 was 11.26 and 8.09 days, respectively.
CONCLUSION: Combination of organized acute stroke unit and short-term ward with early supported discharge reduces the mortality and complications of ischemic stroke patients during admission as well as the length of stay when compared to the general medical ward. The present study reassures that the combination is useful for hospitals in developing countries, which have limited number of beds in their stroke units.

Entities:  

Mesh:

Year:  2007        PMID: 17624201

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  In vivo therapeutic gas delivery for neuroprotection with echogenic liposomes.

Authors:  George L Britton; Hyunggun Kim; Patrick H Kee; Jaroslaw Aronowski; Christy K Holland; David D McPherson; Shao-Ling Huang
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

2.  A 2 DS 2 Score to Predict the Risk of Stroke-Associated Pneumonia in Acute Stroke: An Indian Perspective.

Authors:  Limesh Vyas; Dinkar Kulshreshtha; Pradeep Maurya; Ajai Singh; Abdul Qavi; Anup Thacker
Journal:  J Neurosci Rural Pract       Date:  2019-09-16

Review 3.  Stroke epidemiology in Thailand.

Authors:  Nijasri C Suwanwela
Journal:  J Stroke       Date:  2014-01-31       Impact factor: 6.967

Review 4.  Acute care for the three leading causes of mortality in lower-middle-income countries: A systematic review.

Authors:  Cassidy M Dahn; Olindi Wijesekera; Grace E Garcia; Konrad Karasek; Gabrielle A Jacquet
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.